Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Solid Tumor × toripalimab × Clear all

Phase

Status

Unknown 2 Recruiting 2 Withdrawn 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 2 Solid Tumor 1 Primary Condition: Advanced Tumors 1 Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

vistusertib 2 toripalimab 1 tanespimycin 1 sargramostim 1 roniciclib 1 abemaciclib 1 Letrozole 1 Ipilimumab 1 Hydroxychloroquine 1 Fulvestrant 1 Anastrozole 1 Albumin-Bound Paclitaxel 1 AMG 337 1 4-toluenesulfonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05165849 2022-05-20

A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors

Genfleet Therapeutics (Shanghai) Inc.

Phase 1/2 Withdrawn

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡